Viewing Study NCT03577392


Ignite Creation Date: 2025-12-24 @ 3:24 PM
Ignite Modification Date: 2026-01-10 @ 4:34 PM
Study NCT ID: NCT03577392
Status: UNKNOWN
Last Update Posted: 2019-04-04
First Post: 2018-06-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Recombinant Human Endostatin in Combination With XELOX Therapy in Patient With Advanced Colorectal Cancer.
Sponsor: Sichuan Provincial People's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module